Suppr超能文献

1997年至2004年美国心脏装置植入情况:基于人群的分析。

Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis.

作者信息

Zhan Chunliu, Baine William B, Sedrakyan Artyom, Steiner Claudia

机构信息

Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Rockville, MD, USA.

出版信息

J Gen Intern Med. 2008 Jan;23 Suppl 1(Suppl 1):13-9. doi: 10.1007/s11606-007-0392-0.

Abstract

OBJECTIVE

Use of cardiac devices has been increasing rapidly along with concerns over their safety and effectiveness. This study used hospital administrative data to assess cardiac device implantations in the United States, selected perioperative outcomes, and associated patient and hospital characteristics.

METHODS

We screened hospital discharge abstracts from the 1997-2004 Healthcare Cost and Utilization Project Nationwide Inpatient Samples. Patients who underwent implantation of pacemaker (PM), automatic cardioverter/defibrillator (AICD), or cardiac resynchronization therapy pacemaker (CRT-P) or defibrillator (CRT-D) were identified using ICD-9-CM procedure codes. Outcomes ascertainable from these data and associated hospital and patient characteristics were analyzed.

MEASUREMENTS AND MAIN RESULTS

Approximately 67,000 AICDs and 178,000 PMs were implanted in 2004 in the United States, increasing 60% and 19%, respectively, since 1997. After FDA approval in 2001, CRT-D and CRT-P reached 33,000 and 7,000 units per year in the United States in 2004. About 70% of the patients were aged 65 years or older, and more than 75% of the patients had 1 or more comorbid diseases. There were substantial decreases in length of stay, but marked increases in charges, for example, the length of stay of AICD implantations halved (from 9.9 days in 1997 to 5.2 days in 2004), whereas charges nearly doubled (from $66,000 in 1997 to $117,000 in 2004). Rates of in-hospital mortality and complications fluctuated slightly during the period. Overall, adverse outcomes were associated with advanced age, comorbid conditions, and emergency admissions, and there was no consistent volume-outcome relationship across different outcome measures and patient groups.

CONCLUSIONS

The numbers of cardiac device implantations in the United States steadily increased from 1997 to 2004, with substantial reductions in length of stay and increases in charges. Rates of in-hospital mortality and complications changed slightly over the years and were associated primarily with patient frailty.

摘要

目的

随着对心脏设备安全性和有效性担忧的增加,其使用量一直在迅速上升。本研究利用医院管理数据评估美国心脏设备植入情况、选定的围手术期结局以及相关的患者和医院特征。

方法

我们筛选了1997 - 2004年医疗成本和利用项目全国住院患者样本中的医院出院摘要。使用ICD - 9 - CM程序编码识别接受起搏器(PM)、自动心脏复律除颤器(AICD)或心脏再同步治疗起搏器(CRT - P)或除颤器(CRT - D)植入的患者。分析了可从这些数据中确定的结局以及相关的医院和患者特征。

测量指标和主要结果

2004年美国植入了约67,000个AICD和178,000个PM,自1997年以来分别增长了60%和19%。2001年美国食品药品监督管理局(FDA)批准后,2004年CRT - D和CRT - P在美国每年分别达到33,000台和7,000台。约70%的患者年龄在65岁及以上,超过75%的患者患有一种或多种合并症。住院时间大幅缩短,但费用显著增加,例如,AICD植入的住院时间减半(从1997年的9.9天降至2004年的5.2天),而费用几乎翻倍(从1997年的66,000美元增至2004年的117,000美元)。在此期间,住院死亡率和并发症发生率略有波动。总体而言,不良结局与高龄、合并症和急诊入院相关,并且在不同的结局指标和患者群体中没有一致的值 - 结局关系。

结论

1997年至2004年美国心脏设备植入数量稳步增加,住院时间大幅缩短,费用增加。这些年住院死亡率和并发症发生率变化不大,主要与患者身体虚弱有关。

相似文献

1
Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis.
J Gen Intern Med. 2008 Jan;23 Suppl 1(Suppl 1):13-9. doi: 10.1007/s11606-007-0392-0.
7
Safety of pacemaker implantation in nonagenarians: an analysis of the healthcare cost and utilization project-nationwide inpatient sample.
Circulation. 2013 Apr 9;127(14):1453-65, 1465e1-2. doi: 10.1161/CIRCULATIONAHA.113.001434. Epub 2013 Mar 19.
8
Sex Disparities in the Choice of Cardiac Resynchronization Therapy Device: An Analysis of Trends, Predictors, and Outcomes.
Can J Cardiol. 2021 Jan;37(1):86-93. doi: 10.1016/j.cjca.2020.02.073. Epub 2020 Feb 20.
10
Variation in regional implantation patterns of cardiac implantable electronic device in Switzerland.
PLoS One. 2022 Feb 16;17(2):e0262959. doi: 10.1371/journal.pone.0262959. eCollection 2022.

引用本文的文献

1
Performance of Different Versions of Duke Criteria in Diagnosing Infective Endocarditis in Patients With Intracardiac Prosthetic Materials.
Open Forum Infect Dis. 2025 Aug 19;12(9):ofaf507. doi: 10.1093/ofid/ofaf507. eCollection 2025 Sep.
3
Aging and sinus node dysfunction: mechanisms and future directions.
Clin Sci (Lond). 2025 Jun 11;139(11):577-93. doi: 10.1042/CS20231025.
6
Trends in the 30-year span of noninfectious cardiovascular implantable electronic device complications in Olmsted County.
Heart Rhythm O2. 2024 Feb 14;5(3):158-167. doi: 10.1016/j.hroo.2024.02.001. eCollection 2024 Mar.
7
Cardiac pacing and lead devices management: 25 years of research at EP Europace journal.
Europace. 2023 Aug 25;25(8). doi: 10.1093/europace/euad202.
10
Evaluation of lead-based echodensities on transesophageal echocardiogram in patients with cardiac implantable electronic devices.
J Cardiovasc Electrophysiol. 2023 Jan;34(1):7-13. doi: 10.1111/jce.15727. Epub 2022 Nov 6.

本文引用的文献

1
Pacemaker and ICD malfunction--an incomplete picture.
JAMA. 2006 Apr 26;295(16):1944-6. doi: 10.1001/jama.295.16.1944.
2
Pacemaker and ICD generator reliability: meta-analysis of device registries.
JAMA. 2006 Apr 26;295(16):1929-34. doi: 10.1001/jama.295.16.1929.
5
The National ICD Registry: now and into the future.
Heart Rhythm. 2006 Apr;3(4):470-3. doi: 10.1016/j.hrthm.2006.01.019. Epub 2006 Feb 28.
6
Implantable cardioverter-defibrillators: expanding indications and technologies.
JAMA. 2006 Feb 15;295(7):809-18. doi: 10.1001/jama.295.7.809.
8
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions.
J Am Coll Cardiol. 2005 Dec 20;46(12):2168-82. doi: 10.1016/j.jacc.2005.09.020.
9
Venous thrombosis and stenosis after implantation of pacemakers and defibrillators.
J Interv Card Electrophysiol. 2005 Jun;13(1):9-19. doi: 10.1007/s10840-005-1140-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验